"
Team:Calgary/29 May 2009
From 2009.igem.org
(Difference between revisions)
Emily Hicks (Talk | contribs) |
|||
| (One intermediate revision not shown) | |||
| Line 137: | Line 137: | ||
<br> | <br> | ||
<div class="heading"> | <div class="heading"> | ||
| - | + | iGEM Journal Club | |
</div> | </div> | ||
<br> | <br> | ||
<div class="desc"> | <div class="desc"> | ||
</html> | </html> | ||
| + | Had our weekly meeting. | ||
<html> | <html> | ||
| Line 168: | Line 169: | ||
<div class="desc"> | <div class="desc"> | ||
</html> | </html> | ||
| - | *This morning Fahd, Stefan, Mandy and I attended the Ethics workshop held by AIF. Team members from the U of L and U of A teams were there and we got a chance to meet them and talk about their projects. The first part of the workshop was led by Dr. Gregor Wolbring and Dr. Lori Sheremeta, and we discussed the importantce of ethical considerations in Synthetic Biology. Each team had previously been assigned a team from last year that did well in the Human Practices section of their project and we did research on what they had done. We shared these findings with the rest of the group, explaining what we felt they did well as well as what we felt they could improve on. After this, we shared some of our ideas about what ethical considerations would be important for our own projects. We gave the other teams feedback and | + | *This morning Fahd, Stefan, Mandy and I attended the Ethics workshop held by AIF. Team members from the U of L and U of A teams were there and we got a chance to meet them and talk about their projects. The first part of the workshop was led by Dr. Gregor Wolbring and Dr. Lori Sheremeta, and we discussed the importantce of ethical considerations in Synthetic Biology. Each team had previously been assigned a team from last year that did well in the Human Practices section of their project and we did research on what they had done. We shared these findings with the rest of the group, explaining what we felt they did well as well as what we felt they could improve on. After this, we shared some of our ideas about what ethical considerations would be important for our own projects. We gave the other teams feedback and talked about some of the issues. |
*This workshop really got us thinking about ethical issues and where we want to go with our project in particular. We also got a chance to spend some time getting to know other teams, which was a lot of fun. | *This workshop really got us thinking about ethical issues and where we want to go with our project in particular. We also got a chance to spend some time getting to know other teams, which was a lot of fun. | ||
| - | + | ||
<html> | <html> | ||
| - | |||
</div> | </div> | ||
</td> | </td> | ||
| Line 217: | Line 217: | ||
<br> | <br> | ||
In addition to our own projects, we also examined a number of successful teams from last year and analyzed what the requirements are for the ethics component of iGEM, and what could be explored further this year. The ethics workshop was valuable preparation in outlining exploration of ethics for each project, and the feedback gained from Dr. Wolbring, Ms. Sheremeta, and all of the students provided an excellent starting point. | In addition to our own projects, we also examined a number of successful teams from last year and analyzed what the requirements are for the ethics component of iGEM, and what could be explored further this year. The ethics workshop was valuable preparation in outlining exploration of ethics for each project, and the feedback gained from Dr. Wolbring, Ms. Sheremeta, and all of the students provided an excellent starting point. | ||
| - | |||
| - | |||
<html> | <html> | ||
| Line 244: | Line 242: | ||
<div class="desc"> | <div class="desc"> | ||
</html> | </html> | ||
| - | |||
At the beginning of this week, we were able to make a nice animation from our simulation, using a built-in function called “manipulate”. Our simulation is quit powerful and we believe we can extract more information out of our model. As a result, we designed new ways of representing results, such as “Rule Charts” and “Rule Patterns”. Rule Charts are bar graphs that show the distributions of the rules throughout the simulation. Rule Pattern is an array plot that shows in each step what rule was applied to what membrane using different colors. I also had three meeting this week. The first meeting was with Lindsay members. The second meeting was with Dr. Jacob and Afshin discussing features of our model, and the last meeting was with iGEM people. | At the beginning of this week, we were able to make a nice animation from our simulation, using a built-in function called “manipulate”. Our simulation is quit powerful and we believe we can extract more information out of our model. As a result, we designed new ways of representing results, such as “Rule Charts” and “Rule Patterns”. Rule Charts are bar graphs that show the distributions of the rules throughout the simulation. Rule Pattern is an array plot that shows in each step what rule was applied to what membrane using different colors. I also had three meeting this week. The first meeting was with Lindsay members. The second meeting was with Dr. Jacob and Afshin discussing features of our model, and the last meeting was with iGEM people. | ||
| + | |||
<html> | <html> | ||
</div> | </div> | ||
| Line 277: | Line 275: | ||
</tr> | </tr> | ||
| - | |||
| - | |||
| - | |||
| - | |||
| - | |||
| - | |||
| - | |||
| - | |||
| - | |||
| - | |||
| - | |||
| - | |||
| - | |||
| - | |||
| - | |||
| - | |||
| - | |||
| - | |||
| - | |||
| - | |||
| - | |||
| - | |||
| - | |||
| - | |||
| - | |||
| - | |||
| - | |||
| - | |||
| - | |||
| - | |||
| - | |||
| - | |||
| - | |||
| - | |||
| - | |||
| - | |||
| - | |||
| - | |||
| - | |||
| - | |||
| - | |||
| - | |||
| - | |||
| - | |||
| - | |||
| - | |||
| - | |||
| - | |||
| - | |||
| - | |||
| - | |||
<tr> | <tr> | ||
| Line 379: | Line 326: | ||
<br> | <br> | ||
<div class="heading"> | <div class="heading"> | ||
| - | + | Ethics Workshop | |
</div> | </div> | ||
<br> | <br> | ||
<div class="desc"> | <div class="desc"> | ||
</html> | </html> | ||
| - | + | Today, we attended the ethics workshop with the other 2 Albertan teams. We discussed the E3LS of our respective projects, and learned a bit regarding things that we should explore more into, such as biosafety hazards and patenting/the issues with open source biology. As well, we examined past successful ethics explorations of other iGEM teams and discussed what made them successful, and what we felt was lacking/could be improved upon. | |
| - | + | ||
<html> | <html> | ||
</div> | </div> | ||
| + | <br> | ||
</td> | </td> | ||
</tr> | </tr> | ||
| Line 423: | Line 370: | ||
An 'activatable terminator' very roughly correlates to the idea of an 'operator site', a repressor binding site removed from its promoter. I didn't believe there was any such thing as a 'repressable terminator' (a terminator that is functional by default, but can be disabled by the action of some protein?), until I stumbled across anti-terminators while doing unrelated research much later. The curious are encouraged to look up the proteins N Lambda and Q Lambda. | An 'activatable terminator' very roughly correlates to the idea of an 'operator site', a repressor binding site removed from its promoter. I didn't believe there was any such thing as a 'repressable terminator' (a terminator that is functional by default, but can be disabled by the action of some protein?), until I stumbled across anti-terminators while doing unrelated research much later. The curious are encouraged to look up the proteins N Lambda and Q Lambda. | ||
| - | |||
<html> | <html> | ||
Latest revision as of 03:26, 19 October 2009
UNIVERSITY OF CALGARY
